Tag: Lipoatrophy

Approximately 64% of people with diabetes will develop lipohypertrophy, a common complication from repeated injections, at some point in their life [1.4.3]. Understanding **what are the most common complications of subcutaneous injections** is the first step toward prevention and safe medication administration.

Stavudine, an antiretroviral medication once commonly used for HIV/AIDS, is widely known by at least two other names: its brand name, Zerit, and its chemical shorthand, d4T. It was approved in the US in 1994 and became available as a generic medicine.